PDCD1 and neoplasm: Our previous work identified tumor‐intrinsic PD‐1 as a promotor of tumor progression and an independent prognostic factor in PDAC.[10] To further validate its clinical relevance, we analyzed an independent cohort of 29 PDAC patients.